HIV-1 Integrase Inhibitor 7
CAS No. 1235379-91-5
HIV-1 Integrase Inhibitor 7( —— )
Catalog No. M10942 CAS No. 1235379-91-5
HIV-1 Integrase Inhibitor 7 is an allosteric HIV-1 integrase inhibitor that inhibits the LEDGF/p75-integrase interaction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHIV-1 Integrase Inhibitor 7
-
NoteResearch use only, not for human use.
-
Brief DescriptionHIV-1 Integrase Inhibitor 7 is an allosteric HIV-1 integrase inhibitor that inhibits the LEDGF/p75-integrase interaction.
-
DescriptionHIV-1 Integrase Inhibitor 7 is an allosteric HIV-1 integrase inhibitor that inhibits the LEDGF/p75-integrase interaction with IC50 of 0.58 uM, antiviral activity EC50 of 0.76 uM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1235379-91-5
-
Formula Weight353.48
-
Molecular FormulaC21H23NO2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name2-(2,6-dimethyl-4-(p-tolyl)thieno[2,3-b]pyridin-5-yl)pentanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Christ F, et al. Nat Chem Biol. 2010 Jun;6(6):442-8.
molnova catalog
related products
-
Fostemsavir Tris
Fostemsavir Tris is the prodrug of BMS-626529,is a oral, safe and effective?inhibitor of HIV-1 attachment.?It inhibits human immunodeficiency virus type 1 (HIV-1) infection by binding to gp120 and interfering with the attachment of virus to CD4+ T-cells.
-
Elvitegravir
Elvitegravir (GS-9137, JTK-303) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM in cell-free assays, respectively.
-
Nelfinavir
A potent and orally bioavailable HIV-1 protease inhibitor with Ki of 2 nM.
Cart
sales@molnova.com